• 9 Oct 2025

Claire Sintrat

Claire is a Managing Director at Keensight Capital.

She brings more than 15 years of investment and M&A experience, with a special focus on Healthcare.
Claire was previously Head of M&A at Keensight Performance where she was responsible for the M&A activity across the portfolio.

Prior to joining Keensight, Claire was a Director in the Healthcare Investment Banking team at Jefferies in London. She executed numerous cross-border M&A, equity and debt transactions across a range of healthcare sectors.

Claire also spent part of her career in investment banking at Nomura and HSBC in London, and in Transaction Services at Deloitte.

Claire has a British-French dual nationality. She is a Chartered Accountant and holds a double Bachelor’s degree in European Management, from Lancaster University (UK) and NEOMA Business School (France).

Resources & Insights

  • 15 Jan 2026
  • Jordan Fletcher
Peptide Design in Contemporary DMTA Cycles: How DMTA Drives Translational Refinement
  • Design Make Test Analyse
  • DMTA
  • Peptides
  • Thought Leaders
  • 12 Jan 2026
  • Loïc Roux
Is Fragmented Discovery the Silent Saboteur of Complex Medicines?
  • Design-Make-Test
  • DMTA
  • Drug Discovery
  • Thought Leaders
  • 8 Dec 2025
  • Alison Gordon, Kathy Dodgson, Ryan Mordue, Tom Miller, Vesna Vetma O'Leary
PROductive TACtics Streamlined, multifaceted approaches to unlocking PROTAC® screening insights
  • Bioscience
  • Case Studies
489 KB
  • 2 Dec 2025
CatSci x BRAINBiocatalysts Conference 2026
  • Events